Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider

May 11, 2022 · Biohaven (BHVN) is set to be acquired by Pfizer (PFE) for $11.6 billion in cash. ... Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider. Zacks Equity Research . Wed, …

CouponFollow Extension

$11
OFF

Biohaven (BHVN) Up On PFE's Buyout Offer, Q1 Loss Wider

1 week from now

May 11, 2022 · Biohaven (BHVN) is set to be acquired by Pfizer (PFE) for $11.6 billion in cash. ... Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider. Zacks Equity Research . Wed, …

yahoo.com

182%
OFF

Biohaven (BHVN) Up On PFE's Buyout Offer, Q1 Loss Wider

1 week from now

Total revenues comprised product sales and collaboration revenues. During the quarter, Biohaven generated $123.6 million from Nurtec ODT product sales, up 182% year over year. In the same period, BHVN recorded $195.3 million of collaboration revenues, derived from Pfizer as part of a strategic agreement signed last November. BHVN did not record any...

nasdaq.com

$11
OFF

Biohaven (BHVN) Up On PFE's Buyout Offer, Q1 Loss Wider

1 week from now

May 11, 2022 · Biohaven (BHVN) is set to be acquired by Pfizer (PFE) for $11.6 billion in cash. The transaction is likely to be completed by early 2023. BHVN also reports wider-than …

zacks.com

$11
OFF

Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 …

1 week from now

May 13, 2022 · Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. ... PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update. ... Morgan …

yahoo.com

33%
OFF

BHVN Stock Rockets: Pfizer Snaps Up Biohaven For Nearly $12 …

1 week from now

May 10, 2022 · Pfizer will pay $148.50 per share of BHVN stock and settle Biohaven's third-party debt. The terms value Biohaven stock at a 33% premium to the average volume-weighted …

investors.com

$11
OFF

Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 …

1 week from now

May 13, 2022 8:10AM EDT. This week, Pfizer PFE offered to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer BAYRY announced first-quarter 2022 earnings. …

nasdaq.com

$11
OFF

Pfizer To Buy Biotech Group Biohaven For $11.6bn - Financial Times

1 week from now

May 10, 2022 · Pfizer has agreed to buy US biotech Biohaven Pharmaceuticals for $11.6bn, striking its biggest deal in more than five years as the pharma company bolsters its pipeline of drugs. The New York-based ...

ft.com

$11
OFF

Pfizer To Pay $11.6 Bln For Biohaven To Tap Migraine Market

1 week from now

Show more companies. May 10 (Reuters) - Pfizer Inc (PFE.N) said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co (BHVN.N), making a big bet on its ability to boost ...

reuters.com

$11
OFF

Why Pfizer (PFE) Is Buying Biohaven Pharmaceutical (BHVN) For …

1 week from now

By Amit Chowdhry • May 10, 2022. Pfizer Inc. (NYSE: PFE) announced it is buying Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) in a deal valued at $11.6 billion in cash. …

pulse2.com

$11
OFF

Pfizer To Acquire Biohaven In ~$11.6B Deal; Biohaven Stock Soars …

1 week from now

May 10, 2022 · Pfizer (NYSE:PFE) is acquiring Biohaven (NYSE:BHVN) for a total of ~$11.6B in cash. The two companies have been partners for migraine therapy rimegepant, sold as …

seekingalpha.com

86%
OFF

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports …

1 week from now

May 10, 2022 · Biohaven Pharmaceutical Holding Company Ltd. (BHVN) delivered earnings and revenue surprises of -17.86% and 70.40%, respectively, for the quarter ended March 2022. Do …

zacks.com

$319
OFF

Biohaven Reports Second Quarter 2024 Financial Results And …

1 week from now

Aug 8, 2024 · Net Loss: Biohaven reported a net loss for the three months ended June 30, 2024 of $319.8 million, or $3.64 per share, compared to $90.3 million, or $1.32 per share, for the same period in 2023. Non-GAAP adjusted net loss for the three months ended June 30, 2024 was $307.4 million , or $3.50 per share, compared to $85.7 million , or $1.25 per ...

biohaven.com

7%
OFF

Why Biohaven Stock Is Soaring Today | The Motley Fool

1 week from now

Oct 4, 2022 · Shares of Biohaven Ltd. (BHVN) were soaring 12.7% as of 11:23 a.m. ET on Tuesday after skyrocketing as much as 21.4% earlier in the day. The big gain came after …

fool.com

FAQs about Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider Coupon?

Does Biohaven (bhvn) have any collaboration revenues?

BHVN did not record any collaboration revenues in the year-ago period. Biohaven (BHVN) is set to be acquired by Pfizer (PFE) for $11.6 billion in cash. The transaction is likely to be completed by early 2023. BHVN also reports wider-than-expected Q1 loss. ...

How much did Biohaven lose in first-quarter 2022?

Image Source: Zacks Investment Research In a separate press release, Biohaven also reported first-quarter 2022 results. BHVN incurred a loss of $2.97 per share for first-quarter 2022, wider than the Zacks Consensus Estimate of a loss of $2.52 but narrower than the year-ago loss of $4.21. ...

What is the deal between Biohaven and Pfizer?

Biohaven Pharmaceutical BHVN and Pfizer PFE announced a definitive agreement wherein the latter will acquire the former for $148.50 per share or an aggregate equity value of $11.6 billion. ...

Did Pfizer buy Biohaven & bhvn?

These rights were acquired by PFE last November when it entered into a strategic collaboration agreement with BHVN. PFE also acquired a 2.6% stake in Biohaven. Pfizer will buy the remaining outstanding shares of Biohaven’s common stock at $148.50 each. The acquisition price represents a premium of 78.6% to BHVN’s closing price on May 10. ...

Does Biohaven (bhvn) still have a drug pipeline?

Biohaven (BHVN) is following the same strategy with its remaining drug pipeline as it did prior to Pfizer 's (PFE) massive buyout of the bulk of its assets — and BHVN stock has soared by triple digits since. In October, Pfizer spent $11.6 billion to buy Biohaven's migraine treatment assets, including an already approved drug called Nurtec ODT. ...

What does PFE's acquisition of Biohaven mean for Pfizer?

PFE also acquired a 2.6% stake in Biohaven. Pfizer will buy the remaining outstanding shares of Biohaven’s common stock at $148.50 each. The acquisition price represents a premium of 78.6% to BHVN’s closing price on May 10. ...